GeneDx Holdings Corp. (WGS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for GeneDx Holdings Corp. (WGS:NASDAQ), powered by AI.

Current Price
$34.51
P/E Ratio
-17.7
Market Cap
928M
Sector
Healthcare
What is the GeneDx Holdings Corp. stock price forecast?

GeneDx Holdings Corp. is currently trading at $34.51. View real-time AI analysis on Alpha Lenz.

What is GeneDx Holdings Corp. insider trading activity?

View the latest insider trading data for GeneDx Holdings Corp. on Alpha Lenz.

What is GeneDx Holdings Corp.'s P/E ratio?

GeneDx Holdings Corp.'s P/E ratio is -17.7.

GeneDx Holdings Corp.

NASDAQ · WGS
$34.51-33.42(-49.20%)
Ask about GeneDx Holdings Corp.'s future dividend policy...
Alpha Chat Insight

GeneDx Holdings Corp. trades at a P/E of -17.7 (undervalued) with modest ROE of -22.1%. 3Y revenue CAGR of 12.9% highlights clear growth momentum.

Ask for details

Company Overview

Genedx Holdings Corp is primarily engaged in the complex field of genetic testing and diagnostics. The company focuses on providing unparalleled insights into human genetics, offering a broad array of genomic-based services. These services include clinical diagnostic testing and genomic analyses that play a critical role in personalized medicine. Serving healthcare providers, academic researchers, and pharmaceutical companies, Genedx Holdings Corp leverages its advanced technology platforms to enhance the understanding of genetic and hereditary disorders. The company's extensive test catalog aids in identifying rare and complex genetic conditions, supporting early diagnosis and informed treatment decisions. In the ever-growing biotech industry, Genedx Holdings Corp holds a pivotal position by contributing valuable genetic insights that can lead to groundbreaking therapeutic developments. Its emphasis on precision medicine underscores its importance in modern healthcare, as it helps pave the way for more tailored and effective healthcare solutions.

CEOMs. Katherine A. Stueland
SectorHealthcare
IndustryDiagnostics & Research
Employees1,000

Company Statistics

FY 2024

Profile

$928.02MMarket Cap
$305.45MRevenue
0.00Shares Out
1,000Employees

Margins

63.64%Gross
3.96%EBITDA
-7.60%Operating
-17.23%Pre-Tax
-17.12%Net

Valuation

-17.75P/E
3.78P/B
3.04EV/Sales
79.19EV/EBITDA
-27.30P/FCF

Growth (CAGR)

12.91%Rev 3Yr
9.26%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-12.48%ROA
-22.10%ROE
-5.54%ROIC

Financial Health

$85.21MCash & Cash Equivalents
$88.92MNet Debt
71.00%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

GeneDx Holdings Corp. (ticker: WGS) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 1,000 employees. Market cap is $928M.

The current price is $34.51 with a P/E ratio of -17.75x and P/B of 3.78x.

ROE is -22.10% and operating margin is -7.60%. Annual revenue is $305M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
GeneDx Holdings Corp. (Healthcare) Stock Forecast & Analysis $34.51 | Alpha Lenz